The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Liang, Dongming ^a   Ma, Yuanyuan ^a,b   Liu, Jian ^c   Trope, Claes G ^a,b   Holm, Ruth ^b   Nesland, Jahn M ^a,b   Suo, Zhenhe ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; OCTAMER TRANSCRIPTION FACTOR 4; OXYGEN; TRANSCRIPTION FACTOR SOX2;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INFILTRATION; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXEMIA; IN VITRO STUDY; OVARY CANCER; OXYGEN TENSION; PROTEIN EXPRESSION; STEM CELL; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, CD44; CELL CYCLE; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PEPTIDES; PHENOTYPE; SIDE-POPULATION CELLS; TRANSCRIPTION FACTORS; TUMOR MICROENVIRONMENT;

EID: 84861466196     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-201     Document Type: Article

References (58)

1. Higgins LH, Withers HG, Garbens A, Love HD, Magnoni L, Hayward SW, Moyes CD. Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta 2009, 1787(12):1433-1443. 10.1016/j.bbabio.2009.06.003, 19524545.
2. Jensen RL. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009, 92(3):317-335. 10.1007/s11060-009-9827-2, 19357959.
3. Selvendiran K, Bratasz A, Kuppusamy ML, Tazi MF, Rivera BK, Kuppusamy P. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer 2009, 125(9):2198-2204. 10.1002/ijc.24601, 2893222, 19623660.
4. Sooriakumaran P, Kaba R. Angiogenesis and the tumour hypoxia response in prostate cancer: a review. Int J Surg 2005, 3(1):61-67. 10.1016/j.ijsu.2005.03.013, 17462260.
5. Vaupel P, Briest S, Hockel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 2002, 152(13-14):334-342.
6. Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010, 40(2):294-309. 10.1016/j.molcel.2010.09.022, 3143508, 20965423.
7. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther 2007, 6(10):2609-2617. 10.1158/1535-7163.MCT-07-0234, 17938257.
8. Feldmann HJ. Oxygenation of human tumors-implications for combined therapy. Lung Cancer 2001, 33(Suppl 1):S77-S83.
9. Kunz M, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Mol Cancer 2003, 2:23. 10.1186/1476-4598-2-23, 155638, 12740039.
10. Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA, Mor G. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 2009, 27(10):2405-2413. 10.1002/stem.191, 2783765, 19658191.
11. Burkert J, Wright NA, Alison MR. Stem cells and cancer: an intimate relationship. J Pathol 2006, 209(3):287-297. 10.1002/path.2016, 16770755.
12. Conic I, Dimov I, Tasic-Dimov D, Djordjevic B, Stefanovic V. Ovarian epithelial cancer stem cells. Scientific World J 2011, 11:1243-1269.
13. Curley MD, Garrett LA, Schorge JO, Foster R, Rueda BR. Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer. Front Biosci 2011, 16:368-392. 10.2741/3693, 21196176.
14. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z. Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct Pathol 2009, 33(4):175-181.
15. Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 2011, 18(5):829-840. 10.1038/cdd.2010.150, 3095828,3095828, 21127501.
16. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129(3):465-472. 10.1016/j.cell.2007.04.019, 3150586, 17482542.
17. Mor G, Yin G, Chefetz I, Yang Y, Alvero A. Ovarian cancer stem cells and inflammation. Canc Biol Ther 2011, 11(8):708-713.
18. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010, 102(5):789-795. 10.1038/sj.bjc.6605551, 2833246, 20104230.
19. Rizzino A. Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells. Wiley Interdiscip Rev Syst Biol Med 2009, 1(2):228-236. 10.1002/wsbm.12, 2794141, 20016762.
20. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010, 29(14):2153-2159. 10.1038/onc.2009.500, 20101213.
21. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40(5):499-507. 10.1038/ng.127, 2912221, 18443585.
22. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009, 27(12):2875-2883.
23. Fong MY, Kakar SS. The role of cancer stem cells and the side population in epithelial ovarian cancer. Histol Histopathol 2011, 25(1):113-120.
24. Kusumbe AP, Mali AM, Bapat SA. CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009, 27(3):498-508. 10.1634/stemcells.2008-0868, 19253934.
25. Liu T, Cheng W, Lai D, Huang Y, Guo L. Characterization of primary ovarian cancer cells in different culture systems. Oncol Rep 2010, 23(5):1277-1284.
26. Slomiany MG, Dai L, Tolliver LB, Grass GD, Zeng Y, Toole BP. Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clin Cancer Res 2009, 15(24):7593-7601. 10.1158/1078-0432.CCR-09-2317, 2794991, 19996211.
27. Cannistra SA, DeFranzo B, Niloff J, Ottensmeir C. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. Clin Cancer Res 1995, 1(3):333-342.
28. Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 2010, 102(8):1276-1283. 10.1038/sj.bjc.6605626, 2856005, 20354527.
29. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 2006, 103(30):11154-11159. 10.1073/pnas.0603672103, 1544057, 16849428.
30. Li Y, Bhuiyan M, Sarkar FH. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int J Oncol 1999, 15(3):525-533.
31. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17(10):1253-1270. 10.1101/gad.1061803, 196056, 12756227.
32. Ji L, Liu YX, Yang C, Yue W, Shi SS, Bai CX, Xi JF, Nan X, Pei XT. Self-renewal and pluripotency is maintained in human embryonic stem cells by co-culture with human fetal liver stromal cells expressing hypoxia inducible factor 1alpha. J Cell Physiol 2009, 221(1):54-66. 10.1002/jcp.21826, 19492421.
33. Lee EY, Xia Y, Kim WS, Kim MH, Kim TH, Kim KJ, Park BS, Sung JH. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 2009, 17(4):540-547. 10.1111/j.1524-475X.2009.00499.x, 19614919.
34. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5(3):237-241. 10.1016/j.stem.2009.08.001, 19716359.
35. Zhao T, Zhang CP, Liu ZH, Wu LY, Huang X, Wu HT, Xiong L, Wang X, Wang XM, Zhu LL, et al. Hypoxia-driven proliferation of embryonic neural stem/progenitor cells-role of hypoxia-inducible transcription factor-1alpha. FEBS J 2008, 275(8):1824-1834. 10.1111/j.1742-4658.2008.06340.x, 18341590.
36. Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 2010, 102(2):351-360. 10.1038/sj.bjc.6605486, 2816657, 20010940.
37. Denny WA. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic. Future Oncol 2010, 6(3):419-428. 10.2217/fon.10.1, 20222798.
38. McCarty MF, Barroso-Aranda J, Contreras F. Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy. Med Hypotheses 2010, 74(5):789-797. 10.1016/j.mehy.2009.12.022, 20089365.
39. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29(5):625-634. 10.1038/onc.2009.441, 2969168, 19946328.
40. Box AH, Demetrick DJ. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 2004, 25(12):2325-2335. 10.1093/carcin/bgh274, 15347600.
41. Yoshiba S, Ito D, Nagumo T, Shirota T, Hatori M, Shintani S. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol 2009, 45(2):109-115. 10.1016/j.oraloncology.2008.04.002, 18710819.
42. Huang L, Ao Q, Zhang Q, Yang X, Xing H, Li F, Chen G, Zhou J, Wang S, Xu G, et al. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. J Cancer Res Clin Oncol 2010, 136(3):447-456. 10.1007/s00432-009-0675-4, 19760195.
43. De Bock K, Mazzone M, Carmeliet P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?. Nat Rev Clin Oncol 2011, 8(7):393-404. 10.1038/nrclinonc.2011.83, 21629216.
44. Henze AT, Acker T. Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 2010, 9(14):2749-2763. 10.4161/cc.9.14.12249, 20603601.
45. Cannito S, Novo E, Compagnone A, Valfre di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008, 29(12):2267-2278. 10.1093/carcin/bgn216, 18791199.
46. Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 2008, 8(1):60-67. 10.2174/156652408783565568, 18289014.
47. Hashimoto O, Shimizu K, Semba S, Chiba S, Ku Y, Yokozaki H, Hori Y. Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1alpha-Dependent Manner in Pancreatic Cancer Cells. Pathobiology 2011, 78(4):181-192. 10.1159/000325538, 21778785.
48. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009, 28(45):3949-3959. 10.1038/onc.2009.252, 19718046.
49. Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Canc Res 2010, 12(6):R94.
50. Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI, Tropel P, Patrizi MP, et al. Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential. Cell Tissue Res 2010, 341(1):111-120. 10.1007/s00441-010-0982-8, 20496083.
51. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44(1):240-251.
52. Hiraga T, Ito S, Nakamura H. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential. Oncol Rep 2011, 25(1):289-296.
53. Zhu P, Ning Y, Yao L, Chen M, Xu C. The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia. J Exp Clin Cancer Res 2010, 29:124. 10.1186/1756-9966-29-124, 2944817, 20831794.
54. Pescador N, Villar D, Cifuentes D, Garcia-Rocha M, Ortiz-Barahona A, Vazquez S, Ordonez A, Cuevas Y, Saez-Morales D, Garcia-Bermejo ML, et al. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 2010, 5(3):e9644. 10.1371/journal.pone.0009644, 2837373, 20300197.
55. Kolenda J, Jensen SS, Aaberg-Jessen C, Christensen K, Andersen C, Brunner N, Kristensen BW. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 2011, 103(1):43-58. 10.1007/s11060-010-0357-8, 20835751.
56. Davis SF, Hood J, Thomas A, Bunnell BA. Isolation of adult rhesus neural stem and progenitor cells and differentiation into immature oligodendrocytes. Stem Cells Dev 2006, 15(2):191-199. 10.1089/scd.2006.15.191, 16646665.
57. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26(2):495-502.
58. Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA, Simon MC, Keith B. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006, 20(5):557-570. 10.1101/gad.1399906, 1410808, 16510872.